SCHEMBL7772623

SCHEMBL7772623

CC(C)NC(=O)N1C=CC=CC1

nearest known ligand 0.37

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
P2RX4 Q99571 1/20 0.37
BCHE P06276 1/20 0.36
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4724773 0.74 LMNA (0.35) SMN1; SMN2P2RX4BCHE
SCHEMBL27685582 0.72 P2RX4 (0.36) P2RX4BCHE
SCHEMBL27868729 0.72
SCHEMBL27860620 0.71 PKM (0.35) PKMSMN1; SMN2P2RX4BCHECYP1A2
SCHEMBL29855614 0.71 TSHR (0.33) CYP2D6CYP3A4
SCHEMBL4788208 0.71
SCHEMBL4722936 0.71
SCHEMBL3588715 0.71 MAPK1 (0.35) SMN1; SMN2CYP3A4
SCHEMBL8865924 0.71
SCHEMBL6034344 0.70 ALDH1A1 (0.33) SMN1; SMN2P2RX4BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832887-B1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO CO LTD (JP) 2001-08-08 EP disclosed
US-5962456-A PEPTIC ULCERS SHISEIDO CO., LTD. (JP) 1999-10-05 US disclosed
EP-0832887-A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1998-04-01 EP disclosed